Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake

Clinical and Experimental Nephrology

Volumn 7, Issue 2, 2003, Pages 120-124

  Horikem, Keiji ^a   Usami, Takeshi ^a   Kamiya, Yoshinobu ^a   Kamiya, Takeshi ^a   Yoshida, Atsuhiro ^a   Itoh, Satomi ^b   Yamato, Hideyuki ^b   Ise, Michihito ^b   Kimura, Genjiro ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KUREHA CORPORATION   (Japan)

Author keywords

Phosphate; Progression; Protein intake; Renal failure; Renin angiotensin system

Indexed keywords

ABSORBENT; ALDOSTERONE; ANGIOTENSIN; AST 120; PHOSPHATE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; KIDNEY FAILURE; MALE; NEPHRECTOMY; NONHUMAN; PHOSPHATE METABOLISM; PROTEIN INTAKE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADSORPTION; ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; BODY WEIGHT; CARBON; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; OXIDES; PHOSPHATES; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM;

EID: 0041309766     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-003-0222-6     Document Type: Article

References (27)

1. Sanaka T, Sugino N, Teraoka S, Ota K. Therapeutic effects of oral sorbent in undialyzed uremia. Am J Kidney Dis 1988;12:97-103.
2. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, et al. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991;40:461-9.
3. Yoshida Y, Sakai T, Ise M. Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992;62:305-14.
4. Okada K, Takahashi S. Correction by oral adsorbent of abnormal digestive tract milieu in rats with chronic renal failure. Nephrol Dial Transplant 1995;10:671-6.
5. Owada A, Nakao M, Koike J, Ujiie K, Tomita K, Shiigai T. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Kidney Int 1997:52 (Suppl 63):S188-90.
6. Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994;124:96-104.
7. Miyazaki T, Ise M, Seo H, Niwa T. Indoxyl sulfate increases the gene expressions of TGF-b1, TIMP-1 and pro-a1(I) collagen in uremic rat kidneys. Kidney Int 1997;52 (Suppl 62):S15-22.
8. Klahr S, Levery AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877-84.
9. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983;23:647-55.
10. Anderson S, Brenner BM. Role of intraglomerular hypertension in the initiation and progression of renal failure. In: Kaplan NM, Brenner BM, Laragh JH, editors. The kidney in hypertension. New York: Raven; 1987. p. 67-76.
11. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for The Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
12. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001;135:73-87.
13. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001;285:2719-28.
14. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.
15. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
16. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-8.
17. Mitch WE. Dietary protein restriction in chronic renal failure: nutritional efficacy, compliance, and progression of renal insufficiency. J Am Soc Nephrol 1991;2:823-31.
18. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-9.
19. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58-65.
20. Loghman-Adham M. Role of phosphate retention in the progression of renal failure. J Lab Clin Med 1993;122:16-26.
21. Ibels LS, Alfrey AC, Haut L, Huffer WE. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 1978;298:122-6.
22. Lumlertgul D, Burke TJ, Gillum DM, Alfrey AC, Harris DC, Hammond WS, et al. Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney Int 1986;29:658-66.
23. Sanai T, Okuda S, Motomura K, Onoyama K, Fujishima M. Effect of phosphate binders on the course of chronic renal failure in rats with focal glomerular sclerosis. Nephron 1989;51:530-5.
24. Shimamura T. Prevention of 11-deoxycorticosterone-salt-induced glomerular hypertrophy and glomerulosclerosis by dietary phosphate binder. Am J Pathol 1990;136:549-56.
25. Nakamura M, Suzuki H, Ohno Y, Ohishi A, Yamakawa H, Okada H, et al. Oral calcium carbonate administration ameliorates the progression of renal failure in rats with hypertension. Am J Kidney Dis 1995;25:910-7.
26. Saglikes Y, Massry SG, Iseki K, Brautbar N, Barndt R, Brunton LL, et al. Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat. Am J Physiol 1985;248:F93-9.
27. Murer H, Werner A, Reshkin S, Wuarin F, Biber J. Cellular mechanisms in proximal tubular reabsorption of inorganic phosphate. Am J Physiol 1991;260:C885-99.